Back
Spero Therapeutics Stock Predictions
Sell
35
SPRO
Spero Therapeutics
Last Price:
1.43
Seasonality Move:
-11.72%
7 Day Trial
ALL ACCESS PASS
$
7
Spero Therapeutics Stock Forecast
-
Is Spero Therapeutics Stock Undervalued?
The current Spero Therapeutics [SPRO] share price is $1.43. The Score for SPRO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - SPRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Spero Therapeutics Stock Go Up Next Year?
Data Unavailable
Spero Therapeutics Stock Rating
Data Unavailable
Spero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sperotherapeutics.com
52-Week Data
52-Week High:
1.89
52-Week Low:
0.99
Prediction Charts
Market Cap:
76.93M
Price in USD:
1.43
Volume:
100.63K
Beta:
0.94
Technical Analysis
SMA50:
1.60
SMA100:
1.57
SMA200:
1.41
52-Wk Change:
-19.49%
Stock Predictions
-
Is Spero Therapeutics stock public?
Yes, Spero Therapeutics is a publicly traded company. -
What is the Spero Therapeutics stock quote today?
The Spero Therapeutics stock price is 1.43 USD today. -
How to buy Spero Therapeutics stock online?
You can buy Spero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-9 | 1.66 | 1.69 | 1.70 | 1.65 |
| May-10 | 1.72 | 1.64 | 1.72 | 1.61 |
| May-13 | 1.66 | 1.65 | 1.69 | 1.65 |
| May-14 | 1.64 | 1.60 | 1.66 | 1.60 |
| May-15 | 1.60 | 1.62 | 1.69 | 1.60 |
| May-16 | 1.60 | 1.57 | 1.65 | 1.57 |
| May-17 | 1.60 | 1.59 | 1.61 | 1.53 |
| May-20 | 1.60 | 1.56 | 1.60 | 1.53 |
| May-21 | 1.52 | 1.51 | 1.56 | 1.50 |
| May-22 | 1.50 | 1.51 | 1.52 | 1.48 |
| May-23 | 1.51 | 1.48 | 1.51 | 1.45 |
| May-24 | 1.46 | 1.47 | 1.50 | 1.45 |
| May-28 | 1.47 | 1.43 | 1.48 | 1.43 |
| May-29 | 1.42 | 1.43 | 1.43 | 1.41 |
Spero Therapeutics Earnings
Data Unavailable
Spero Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.53 per share, and an increase next year of $0.02 per share.
* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.